Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 2 SUPPL., 1997, Pages 327-333

  Zelefsky, Michael J ^a   Aschkenasy, Eric ^a   Kelsen, Suzanne ^a   Leibel, Steven A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adjuvant therapy; Prostate specific antigen; Prostatectomy; Three dimensional conformal radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; GASTROINTESTINAL TOXICITY; HUMAN; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; STRESS INCONTINENCE; UROGENITAL TRACT DISEASE;

EID: 0030828994     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00056-4     Document Type: Article

References (25)

1. Anscher, M. S., Prosnitz, L. R. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J. Urol. 138:1407-1412; 1987.
2. Anscher, M. S.; Robertson, C. N.; Prosnitz, L. R. Adjuvant radiotherapy for pathologic stage T3/T4 adenocarcinoma of the prostate: Ten year update. Int. J. Radiat. Oncol. Biol. Phys. 33:37-43; 1995.
3. Anscher, M. S.; Prosnitz, L. R. Multivariate analysis of factors predicting local relapse after radical prostatectomy-possible indications for postoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 21:941-947; 1991.
4. Buskirk, S. J.; Schild, S. E.; Durr, E. D.; Robinow, J. S.; Bock, F. F.; Wolfe, J. T.; Tomera, K. M.; Ferrigni, R. G. Evaluation of serum prostate specific antigen levels after posterative radiation therapy for pathologic stage T3, NO prostate cancer. Mayo Clin. Proc. 71:242-248; 1996.
5. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B.43:187-220; 1972.
6. Eisbruch, A.; Perez, C. A.; Roessler, E. H.; Lockett, M. A. Adjuvant irradiation after prostatectomy for carcinoma with positive surgical margins. Cancer 73:384-387; 1994.
7. Forman, J. D.; Wharam, M. D.; Lee, D. J.; Zinreich, E. S.; Order, S. E. Definitive radiotherapy following prostatectomy: Results and complications. Int. J. Radiat. Biol. Phys. 12:185-189; 1986.
8. Forman, J. D.; Duclos, M.; Shamsa, F.; Pontes, E. J. Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation. Urology 47:382-386; 1996.
9. Frazier, H. A.; Robertson, J. E.; Humphrey, P. A.; Paulson, D. F. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. J. Urol. 149:516-518; 1993.
10. Gibbons, R. B.; Cole, B. S.; Richardson, R. G.; Correra, R J.; Brannen, G. E.; Mason, J. T.; et al. Adjuvant radiotherapy following radical prostatectomy: results and complications. J. Urol. 135:73-76; 1986.
11. Kaplan, E. L.; Meier, P. Nonparametic estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-816; 1958.
12. Lange, P. H.; Lightner, D. J.; Medini, E.; Reddy, P. K.; Vasella, R. L. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J. Urol. 144:927-932; 1990.
13. Lawton, C. A.; Won, M.; Pilepich, M. V.; Asbell, S. O.; Shipley, W. U.; Hanks, G. E.; Cox, J. D.; Perez, C. A.; Sauge, W.; Doggett, S. R. L.; Rubin, P. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706, Int. J. Radiat. Oncol. Biol. Phys. 21:935-936; 1991.
14. Leibel, S. A.; Zelefsky, M. J.; Kutcher, G. J.; Burman, C. M.; Mohan, R.; Mageras, G. S.; Ling, C. C.; Fuks, Z. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin. Oncol. 21:580-597; 1994.
15. Lightner, D. J.; Lange, P. H.; Reddy, P. K.; Moore, L. Prostate specific antigen and local recurrence after radical prostatectomy. J. Urol. 144: 921-926; 1990.
16. Mantel, N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemo Rep. 50:163-170; 1966.
17. McCarthy, J. F.; Catalona, W. J.; Hudson, M. A. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy; Early versus delayed treatment. J. Urol. 151:1575-1578; 1994.
18. Partin, A. W.; Borland, R. N.; Epstein, J. I.; Brendler, C. B. Influence of wide excision of the neurovascular bundle (s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J. Urol. 150:142-148; 1993.
19. Petrovich, Z.; Lieskovsky, G.; Langholz, B.; Luxton, G.; Jozsef, G.; Skinner, D. G. Radiotherapy following radical prostatectomy in patients with adenocarcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 21:949-954; 1991.
20. Pilepich, M. V.; Walz, B. J.; Baglan, R. J. Postoperative irradiation in carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 10:1869-1873; 1984.
21. Ray, G. R.; Bagshaw, M. A.; Freiha, F. External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J. Urol. 132:926-930; 1984.
22. Shevlin, B. E.; Mittal, B. B.; Brand, W. N.; Shetty, R. M. The role adjuvant irradiation following primary prostatectomy based on histopathologic extent of tumor. Int. J. Radiat. Oncol. Biol. Phys. 16:1425-1430; 1989.
23. Stein, A.; deKernion, J. B.; Smith, R. B.; Dorey, F.; Patel. H. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J. Urol. 147:942-946; 1992.
24. Wu, J. J.; King, S. C.; Montana, G. S.; McKinstry, C. A.; Anscher, M. S. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int. J. Radiat. Oncol. Biol. Phys. 32:317-323; 1995.
25. Zelefsky, M. J.; Leibel, S. A.; Kutcher, G. J.; Kelson, S.; Ling, C. C.; Fuks, Z. The feasibility of dose escalation with 3-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J. Sci. Am. 1:142-150; 1995.